The Joint Corp. (JYNT), has announced a $5 million stock repurchase program, authorized by its board of directors. The program is expected to begin in August 2025 and may continue through June 3, 2027, unless suspended or terminated earlier.
The company said the buyback reflects strong confidence in its long-term strategy, refranchising efforts, and cash flow generation.
CEO Sanjiv Razdan emphasized that the stock may be undervalued relative to its growth potential and franchise model.
Repurchases may be made via open market transactions, private deals, or other methods, and will be guided by market conditions and legal requirements.
There is no obligation to repurchase any specific number of shares.
Headquartered in Scottsdale, Arizona, The Joint operates over 950 chiropractic clinics nationwide and logs more than 14 million patient visits annually. The company continues to be recognized for franchise excellence and innovation in retail healthcare delivery.
Currently, JYNT is trading at $13.24, up by 19.17 percent on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.